JP2004504808A5 - - Google Patents

Download PDF

Info

Publication number
JP2004504808A5
JP2004504808A5 JP2001570749A JP2001570749A JP2004504808A5 JP 2004504808 A5 JP2004504808 A5 JP 2004504808A5 JP 2001570749 A JP2001570749 A JP 2001570749A JP 2001570749 A JP2001570749 A JP 2001570749A JP 2004504808 A5 JP2004504808 A5 JP 2004504808A5
Authority
JP
Japan
Prior art keywords
sequences
seq
polynucleotide
nos
identity
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2001570749A
Other languages
English (en)
Japanese (ja)
Other versions
JP2004504808A (ja
Filing date
Publication date
Priority claimed from US09/570,737 external-priority patent/US7202342B1/en
Priority claimed from US09/593,793 external-priority patent/US7517952B1/en
Priority claimed from US09/636,215 external-priority patent/US6620922B1/en
Priority claimed from US09/651,236 external-priority patent/US6818751B1/en
Priority claimed from US09/657,279 external-priority patent/US6894146B1/en
Priority claimed from US09/679,426 external-priority patent/US6759515B1/en
Priority claimed from US09/685,166 external-priority patent/US6630305B1/en
Application filed filed Critical
Priority claimed from PCT/US2001/009919 external-priority patent/WO2001073032A2/en
Publication of JP2004504808A publication Critical patent/JP2004504808A/ja
Publication of JP2004504808A5 publication Critical patent/JP2004504808A5/ja
Pending legal-status Critical Current

Links

JP2001570749A 2000-03-27 2001-03-27 前立腺癌の治療及び診断のための組成物及び方法 Pending JP2004504808A (ja)

Applications Claiming Priority (12)

Application Number Priority Date Filing Date Title
US53685700A 2000-03-27 2000-03-27
US56810000A 2000-05-09 2000-05-09
US09/570,737 US7202342B1 (en) 1999-11-12 2000-05-12 Compositions and methods for the therapy and diagnosis of prostate cancer
US09/593,793 US7517952B1 (en) 1997-02-25 2000-06-13 Compositions and methods for the therapy and diagnosis of prostate cancer
US60578300A 2000-06-27 2000-06-27
US09/636,215 US6620922B1 (en) 1997-02-25 2000-08-09 Compositions and methods for the therapy and diagnosis of prostate cancer
US09/651,236 US6818751B1 (en) 1997-08-01 2000-08-29 Compositions and methods for the therapy and diagnosis of prostate cancer
US09/657,279 US6894146B1 (en) 1997-02-25 2000-09-06 Compositions and methods for the therapy and diagnosis of prostate cancer
US09/679,426 US6759515B1 (en) 1997-02-25 2000-10-02 Compositions and methods for the therapy and diagnosis of prostate cancer
US09/685,166 US6630305B1 (en) 1999-11-12 2000-10-10 Compositions and methods for the therapy and diagnosis of prostate cancer
US70972900A 2000-11-09 2000-11-09
PCT/US2001/009919 WO2001073032A2 (en) 2000-03-27 2001-03-27 Compositions and methods for the therapy and diagnosis of prostate cancer

Publications (2)

Publication Number Publication Date
JP2004504808A JP2004504808A (ja) 2004-02-19
JP2004504808A5 true JP2004504808A5 (enrdf_load_stackoverflow) 2008-05-15

Family

ID=27582800

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2001570749A Pending JP2004504808A (ja) 2000-03-27 2001-03-27 前立腺癌の治療及び診断のための組成物及び方法

Country Status (5)

Country Link
EP (1) EP1311673A2 (enrdf_load_stackoverflow)
JP (1) JP2004504808A (enrdf_load_stackoverflow)
AU (1) AU2001249549A1 (enrdf_load_stackoverflow)
CA (1) CA2403909A1 (enrdf_load_stackoverflow)
WO (1) WO2001073032A2 (enrdf_load_stackoverflow)

Families Citing this family (39)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030185830A1 (en) * 1997-02-25 2003-10-02 Corixa Corporation Compositions and methods for the therapy and diagnosis of prostate cancer
US7517952B1 (en) 1997-02-25 2009-04-14 Corixa Corporation Compositions and methods for the therapy and diagnosis of prostate cancer
DE69840669D1 (de) 1997-04-10 2009-04-30 Stichting Katholieke Univ Pca3, pca3-gene und verfahren zu ihrer verwendung
US7037667B1 (en) 1998-06-01 2006-05-02 Agensys, Inc. Tumor antigen useful in diagnosis and therapy of prostate and colon cancer
US20030149531A1 (en) 2000-12-06 2003-08-07 Hubert Rene S. Serpentine transmembrane antigens expressed in human cancers and uses thereof
PT1086223E (pt) 1998-06-01 2009-11-03 Agensys Inc Novos antigénios transmembranares em serpentina expressos em cancros humanos e suas utilizações
US6833438B1 (en) 1999-06-01 2004-12-21 Agensys, Inc. Serpentine transmembrane antigens expressed in human cancers and uses thereof
US7083796B2 (en) 2000-06-20 2006-08-01 Corixa Corporation Fusion proteins of mycobacterium tuberculosis
US6943235B1 (en) 1999-04-12 2005-09-13 Agensys, Inc. Transmembrane protein expressed in prostate cancer
JP2003510075A (ja) 1999-09-29 2003-03-18 ディグノキュアー・インコーポレーテッド 良性および悪性の前立腺組織におけるｐｃａ３メッセンジャーｒｎａ種
US7361338B2 (en) 1999-10-05 2008-04-22 Agensys, Inc. Methods to inhibit growth of prostate cancer cells
US7208280B2 (en) 1999-10-05 2007-04-24 Agensys, Inc. Nucleic acid and corresponding protein entitled 101P3A41 useful in treatment and detection of cancer
US6790631B1 (en) 1999-10-05 2004-09-14 Agensys, Inc. G protein-coupled receptor up-regulated in prostate cancer and uses thereof
ES2282142T3 (es) * 1999-10-07 2007-10-16 Corixa Corporation Una secuencia de micobacterium tuberculosis para la expresion de proteinas heterologas.
US7776523B2 (en) 2000-12-07 2010-08-17 Novartis Vaccines And Diagnostics, Inc. Endogenous retroviruses up-regulated in prostate cancer
WO2002083921A2 (en) 2001-04-10 2002-10-24 Agensys, Inc. Nuleic acids and corresponding proteins useful in the detection and treatment of various cancers
JP2005504513A (ja) * 2001-05-09 2005-02-17 コリクサ コーポレイション 前立腺癌の治療及び診断のための組成物及び方法
CA2447564A1 (en) * 2001-05-15 2002-11-21 Agensys, Inc. Nucleic acids and corresponding proteins entitled 101p3a11 or phor-1 useful in treatment and detection of cancer
US6897024B2 (en) 2001-05-31 2005-05-24 Stichting Katholieke Universiteit More Particularly The University Medical Centre Nijmegen Nucleic acid molecules comprising the promoter for PCA3, and uses thereof
US7229774B2 (en) 2001-08-02 2007-06-12 Regents Of The University Of Michigan Expression profile of prostate cancer
US7332290B2 (en) 2001-08-02 2008-02-19 The Regents Of The University Of Michigan Dectection of AMACR cancer markers in urine
US7700293B2 (en) 2001-08-02 2010-04-20 The Regents Of The University Of Michigan Expression profile of prostate cancer
US7494646B2 (en) 2001-09-06 2009-02-24 Agensys, Inc. Antibodies and molecules derived therefrom that bind to STEAP-1 proteins
AU2002336446B2 (en) 2001-09-06 2008-03-06 Agensys, Inc. Nucleic acid and corresponding protein entitled STEAP-1 useful in treatment and detection of cancer
AU2003210663A1 (en) 2002-01-25 2003-09-02 The Regents Of The University Of California Methods of modulating cold sensory perception
MXPA04012443A (es) * 2002-06-11 2005-04-19 Glaxosmithkline Biolog Sa Composiciones inmunogenicas.
US20040081653A1 (en) 2002-08-16 2004-04-29 Raitano Arthur B. Nucleic acids and corresponding proteins entitled 251P5G2 useful in treatment and detection of cancer
WO2004070056A2 (en) 2003-02-07 2004-08-19 Diagnocure Inc. Method to detect prostate cancer in a sample
EP1742966B1 (en) 2004-04-22 2013-11-27 Agensys, Inc. Antibodies and molecules derived therefrom that bind to steap-1 proteins
CA2491067A1 (en) 2004-12-24 2006-06-24 Stichting Katholieke Universiteit Mrna rations in urinary sediments and/or urine as a prognostic marker for prostate cancer
WO2006134917A1 (ja) * 2005-06-14 2006-12-21 Dnavec Corporation 抗体の作製方法
WO2007035676A2 (en) 2005-09-19 2007-03-29 Veridex., Llc Methods and materials for identifying the origin of a carcinoma of unknown primary origin
US7622573B2 (en) * 2006-01-17 2009-11-24 Biolex, Inc. Expression control elements from the lemnaceae family
US7820174B2 (en) 2006-02-24 2010-10-26 The United States Of America As Represented By The Department Of Health And Human Services T cell receptors and related materials and methods of use
WO2007100568A2 (en) * 2006-02-24 2007-09-07 Government Of The United States Of America, Represented By The Secretary, Department Of Health And Human Services T cell receptors and related materials and methods of use
WO2008052187A2 (en) 2006-10-27 2008-05-02 Genentech. Inc. Antibodies and immunoconjugates and uses therefor
GB201513921D0 (en) * 2015-08-05 2015-09-23 Immatics Biotechnologies Gmbh Novel peptides and combination of peptides for use in immunotherapy against prostate cancer and other cancers
CA3055132A1 (en) 2017-04-03 2018-10-11 F. Hoffmann-La Roche Ag Antibodies binding to steap-1
EP4584297A1 (en) * 2022-09-11 2025-07-16 Yeda Research and Development Co. Ltd Anti-klk4 antibodies and uses thereof

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU727823B2 (en) * 1997-02-19 2000-12-21 Jcam Agri. Co., Ltd. Granular fertilizer coated with degradable film and method for producing the same
US20030185830A1 (en) * 1997-02-25 2003-10-02 Corixa Corporation Compositions and methods for the therapy and diagnosis of prostate cancer
IL131539A0 (en) * 1997-02-25 2001-01-28 Corixa Corp Compounds for immunodiagnosis of prostate cancer and methods for their use
IL140845A0 (en) * 1998-07-14 2002-02-10 Corixa Corp Compositions for therapy and diagnosis of prostate cancer
WO2001025272A2 (en) * 1999-10-04 2001-04-12 Corixa Corporation Compositions and methods for therapy and diagnosis of prostate cancer
CA2391369A1 (en) * 1999-11-12 2001-05-17 Corixa Corporation Compositions and methods for the therapy and diagnosis of prostate cancer
HUP0203968A3 (en) * 2000-01-14 2004-09-28 Corixa Corp Seattle Compositions and methods for the therapy and diagnosis of prostate cancer
JP2005504513A (ja) * 2001-05-09 2005-02-17 コリクサ コーポレイション 前立腺癌の治療及び診断のための組成物及び方法

Similar Documents

Publication Publication Date Title
JP2004504808A5 (enrdf_load_stackoverflow)
JP2004512022A5 (enrdf_load_stackoverflow)
Miura et al. Molecular cloning of nucleobindin, a novel DNA-binding protein that contains both a signal peptide and a leucine zipper structure
JP5047996B2 (ja) 糸球体腎炎および他の炎症性疾患の治療のための組成物および方法
RU2743016C2 (ru) Улучшение иммуногенности пептида l2 впч
FR2772047B1 (fr) Sequence genomique et polypeptides de circovirus associe a la maladie de l'amaigrissement du porcelet (map), applications au diagnostic et a la prevention et/ou au traitement de l'infection
WO2001021810B1 (en) Chlamydia antigens and corresponding dna fragments and uses thereof
JP2009291218A (ja) 髄膜炎菌種の細菌に特異的なｄｎａおよび蛋白質またはペプチド、それらの取得方法およびそれらの生物学的応用
CA2938731A1 (en) Methods of treating alzheimer's disease
JP2006515749A5 (enrdf_load_stackoverflow)
JP2008508859A5 (enrdf_load_stackoverflow)
JP2010532657A5 (enrdf_load_stackoverflow)
CA2332570A1 (en) Uses of the borreliacidal epitope(s) of borrelia burgdorferi outer surface protein c (ospc) as vaccine
JP5926194B2 (ja) Ｆｅｃｖ及びｆｉｐｖを区別する為の手段及び方法
JP2002531522A5 (enrdf_load_stackoverflow)
TW210355B (enrdf_load_stackoverflow)
JP2007513604A (ja) 新規エンテロウイルス、ワクチン、医薬および診断キット
JP2017500883A (ja) 癌とｃｎｓの疾患の将来の進行のための初期マーカーおよび癌治療および予防のための標的としてのｈｃｂｉ配列
JP2001521744A5 (enrdf_load_stackoverflow)
JP2002512005A5 (enrdf_load_stackoverflow)
JP2010517544A5 (enrdf_load_stackoverflow)
EP3535412B1 (en) Phage-based detection of borreliosis and means therfor.
CA2343980A1 (en) Mammaglobin, a secreted mammary-specific breast cancer protein
FR2771751A1 (fr) Erythrovirus et ses applications
WO1991014779A1 (en) Diagnostic for hepatitis virus